Clostridium Difficile Associated Diarrhea in Children with Hematological Malignancy-Experience from a Pediatric Oncologic Centre, Bangladesh
Creators
- 1. Pediatric Hematology and Oncology Department, National Institute of Cancer Research and Hospital, Bangladesh
- 2. Department of Pediatric Hematology and Oncology, Bangabandhu Sheikh Mujib Medical University, Bangladesh
- 3. Infectious Disease Division, International Centre for Diarrheal Disease Research, Bangladesh
- 4. Centre for Medical Education, Bangladesh
Description
Background: Clostridium difficile Associated Diarrhea (CDAD) is considered to be one of the commonest
causes of nosocomial diarrhoea worldwide. Gastrointestinal infections in the form of diarrhoea are common in pediatric
oncology patients in Bangabandhu Sheikh Mujib Medical University (BSMMU), Bangladesh. The study was conducted to
find out the frequency of Clostridium difficile infection (CDI) among diarrheal children with haematological malignancy.
Materials and Methods: This prospective observational study was conducted from April 2012 to March 2013 at the
Pediatric Hematology and Oncology Unit, BSMMU, Bangladesh. Total 58 diarrheal episodes occurred in 51 children with
various types of haematological malignancies were included consecutively. Faecal samples of the children were sent to
International Centre for Diarrheal Disease Research, Bangladesh (ICDDR, B) laboratory for detection of Clostridium
difficile antigen (GDH) and toxins (A and/ or B) by Enzyme Immunoassay (EIA).
Results: Among 58 diarrheal episodes 22.4% faecal samples were positive for GDH, but none of the faecal samples was
positive for toxin A and or B. There were a significant association with leucopenia, severe neutropenia; usage of
meropenem plus vancomycin, cefepime plus amikacin, imipenem, cytarabine and omeprazole with GDH positive
diarrheal episodes.
Conclusion: Positive GDH antigen with a negative result for toxin indicates C. difficile colonization. Among GDH positive
episodes, a significantly higher proportion of children had leucopenia, severe neutropenia and usage of some drugs
known as risk factors for C. difficile infection. To confirm the CDI advanced tests are needed.
Files
IJCHNV8N4A6-Ferdousi.pdf
Files
(194.4 kB)
Name | Size | Download all |
---|---|---|
md5:6cd08e167127a434e3ad8fcd9d3c86fb
|
194.4 kB | Preview Download |
Additional details
References
- Coffin SE, Zaoutis TE. Infection control, hospital epidemiology, and patient safety. Infect Dis Clin North Am 2005; 19(3): 647-65. https://doi.org/10.1016/j.idc.2005.05.002
- Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011; 8: 17-26. https://doi.org/10.1038/nrgastro.2010.190
- Dubberke ER, Wertheimer AL. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30(1): 57-66. https://doi.org/10.1086/592981